Ségolène Aymé
INSERM
May Orfali MD
Pfizer
Jonathan Appleby PhD
GSK Rare Diseases
Christian Girard
ORPHAN DRUGS INDUSTRY
Michael Zaiac
Celgene
Dr. M. (Ken) Kengatharan
Armatheon Inc
Jasper Dingemanse
Actelion
Dr. Mary Reilly
Opsona Therapeutics
Alastair Kent OBE
Genetic Alliance UK
Christelle Huguet
Alexion Pharmaceuticals
Dr. George Dickson
Royal Holloway, University of ...
Nicholas Adlard
Novartis Pharma
Rolando Gutierrez
Covance Inc
Kay Parkinson
CRDM
Friedhelm Hornig
Cytel
Myra Herrle
AbbVie
Pete Chan
Raremark
Dr. Anthony Hall
Mereo BioPharma
Joseph B. Musumeci
BluePrint Orphan
Adam Hutchings
Dolon
Steven Zimmer
MytoDys Therapeutics
Susan Carter
Cote Orphan
Dr. Terence Eagleton
Medpace
Angela Ward
Complete HealthVizion
Jane Blyth
Complete HealthVizion
Sjef De Kimpe
BioMarin
Owen Marks
Pfizer
Dr. med. Jan Geldmacher
AKDÄ
